7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 
      
    		                                       
      cash flow from operating activities
    		                                       
      net income
    		-25,117,000 -53,235,000 -76,088,000 -45,395,000 -62,141,000 -67,607,000 -61,950,000 -18,874,000 -45,019,000 -40,290,000 -49,036,000 -60,738,000 -55,726,000 -53,453,000 -50,515,000 -41,436,000 -39,082,000 -55,256,000 -56,728,000 -62,499,000 7,819,000 -23,572,000 -37,724,000 -37,770,000 -32,941,000 -33,786,000 -29,249,000 -25,055,000 -15,238,000 -38,722,000 -30,939,000  -26,599,000 -26,439,000 -31,097,000  -21,020,000 -19,042,000 -17,745,000 
      adjustments to reconcile net income to net cash from operating activities:
    		                                       
      stock-based compensation expense
    		2,228,000 2,664,000 2,979,000 4,020,000 4,802,000 5,010,000 7,585,000 5,345,000 4,731,000 5,215,000 4,507,000 5,364,000 5,881,000 6,618,000 11,431,000 7,657,000 10,012,000 13,526,000 12,204,000 5,673,000 5,846,000 5,417,000 6,220,000 6,336,000 6,559,000 6,493,000 7,855,000 6,347,000 6,699,000 7,024,000 6,528,000  4,467,000 5,016,000 5,804,000  3,690,000 5,199,000 4,210,000 
      depreciation
    		721,000 1,834,000 1,917,000 1,381,000 1,599,000 1,420,000 1,409,000 1,466,000 1,514,000 1,540,000 1,544,000 1,577,000 1,604,000 1,598,000 1,558,000 1,511,000 1,190,000 1,189,000 1,163,000 1,183,000 1,107,000 871,000 798,000 782,000 727,000 693,000 628,000 880,000 839,000 784,000 751,000  684,000 651,000 631,000  281,000 246,000 187,000 
      loss on disposal of fixed assets
    		0   10,000     0 0 1,583,000                             
      net accretion of discounts on marketable securities
    		                                       
      interest related to sale of future revenues
    		2,399,000 2,091,000 2,145,000                                     
      impairment of held for sale assets
    		0 0 3,724,000                                     
      other non-cash items
    		0 -882,000 492,000 0 0     -780,000 -693,000 -498,000 -283,000 -177,000 234,000 325,000 422,000 509,000 401,000 389,000 4,000 -74,000 -215,000 -501,000 -468,000 -778,000 -1,181,000 -1,139,000 -1,031,000 -668,000 -430,000  -193,000 107,000 69,000     
      changes in operating assets and liabilities:
    		                                       
      accounts receivable
    		-7,542,000 -78,000 15,756,000 -16,140,000 118,000 1,000 9,942,000 -7,765,000 -136,000 -2,044,000 4,903,000 -5,025,000 593,000 659,000 -1,105,000 -16,000 80,000 341,000 5,376,000 -4,993,000 810,000 -33,000 -1,414,000 -107,000 -299,000 -12,000 30,000 13,000 319,000 569,000 -252,000  125,000 125,000 -857,000  73,000 -87,000 -89,000 
      prepaid expenses and other current assets
    		593,000 -488,000 70,000 2,789,000 1,072,000 2,142,000 -1,607,000 -968,000 160,000 -947,000 1,558,000 -444,000 1,215,000 -809,000 -99,000 2,317,000 -4,107,000 903,000 4,618,000 -462,000 -927,000 -1,259,000 -1,995,000 -758,000 -38,000 -488,000 789,000 -1,061,000 -935,000 -653,000 -761,000  228,000 -972,000 486,000  -80,000 -499,000 -1,088,000 
      right-of-use assets
    		1,428,000 2,569,000 6,125,000 3,174,000 1,223,000 -5,508,000 2,237,000 -1,744,000 2,875,000 1,533,000 7,304,000 -21,116,000 -1,866,000 2,791,000 2,716,000 2,611,000 2,513,000 8,744,000 -4,177,000 1,270,000 2,171,000 -1,547,000 1,739,000                 
      other non-current assets
    		1,000 0 1,025,000 60,000 2,863,000 1,342,000 -899,000 -2,833,000   -1,500,000 2,277,000 0 -214,000 -505,000 -31,000 0 -92,000 -1,985,000 -825,000 13,000 0 93,000 -1,000    0 0    0 0 2,000  11,000 -24,000 2,248,000 
      accounts payable
    		-3,561,000 1,258,000 -27,000 -6,999,000 -1,254,000 7,423,000 -1,456,000 -2,594,000 2,358,000 -699,000 -557,000 2,694,000 422,000 1,481,000 -229,000 1,839,000 -1,160,000 -3,835,000 2,017,000 1,302,000 -1,473,000 -3,741,000 4,767,000 -731,000 2,464,000 -2,085,000 626,000 113,000 683,000 -4,111,000 5,095,000  -803,000 -6,712,000 10,078,000  -2,164,000 3,715,000 544,000 
      accrued expenses
    		-543,000 578,000 1,693,000 17,146,000 1,015,000 -3,844,000 -2,694,000 4,092,000 2,382,000 -3,787,000 1,427,000 10,990,000 -887,000 4,384,000 -3,982,000 5,273,000 -3,423,000 3,547,000 -9,563,000 4,098,000 10,048,000 1,205,000 -13,644,000 13,976,000 136,000 2,296,000 -6,923,000 1,698,000 312,000 3,284,000 -1,252,000  -2,762,000 4,339,000 -10,539,000  1,900,000 320,000 1,814,000 
      accrued interest on sale of future revenues
    		0 0 -2,128,000                                     
      deferred revenue
    		0 -2,000,000 -4,221,000         0 0 2,183,000 -5,516,000 -11,334,000 -5,666,000 -151,000 -5,555,000 -5,768,000 -78,651,000 -3,066,000 -4,309,000 58,323,000 -3,549,000 2,682,000 -2,061,000 18,501,000 511,000 7,019,000 -3,142,000  -3,103,000 -2,277,000 90,214,000  158,000 163,000 158,000 
      operating lease liabilities
    		-1,483,000 -5,149,000 -3,899,000 -3,456,000 -210,000 4,558,000 -2,396,000 1,925,000 -2,575,000 48,000 -6,808,000 22,646,000 1,043,000 -2,906,000 -3,215,000 -3,298,000 -1,564,000 -8,382,000 2,750,000 -575,000 -2,093,000 1,624,000 -1,902,000                 
      other non-current liabilities
    		95,000 -1,310,000 3,221,000  -488,000                                   
      net cash from operating activities
    		-30,843,000 -50,212,000 -47,799,000 -50,762,000 -52,588,000 -57,062,000 -49,872,000 -22,240,000 -35,459,000 -38,711,000 -35,768,000 -42,273,000 -48,004,000 -37,845,000 -49,227,000 -34,582,000 -40,785,000 -38,957,000 -49,479,000 -40,100,000 -54,801,000 -30,856,000 -54,086,000 41,024,000 -26,884,000 -25,806,000 -29,003,000 1,327,000 -7,841,000 -16,733,000 -22,460,000  -27,977,000 -26,162,000 69,791,000  -17,041,000 -9,899,000 -9,629,000 
      capex
    		-433,000 0 -114,000 -540,000 -2,921,000 -3,494,000 -1,871,000 -1,307,000 -239,000 -1,333,000 -1,840,000 -624,000 -614,000 -632,000 -2,248,000 -2,845,000 -2,344,000 -2,704,000 -84,000 -1,376,000 -1,793,000 -1,841,000 -2,152,000 -1,691,000 -2,245,000 -1,513,000 -718,000 -1,415,000 -938,000 -1,390,000 -1,011,000  -752,000 -362,000 -656,000  -713,000 -1,161,000 -943,000 
      free cash flows
    		-31,276,000 -50,212,000 -47,913,000 -51,302,000 -55,509,000 -60,556,000 -51,743,000 -23,547,000 -35,698,000 -40,044,000 -37,608,000 -42,897,000 -48,618,000 -38,477,000 -51,475,000 -37,427,000 -43,129,000 -41,661,000 -49,563,000 -41,476,000 -56,594,000 -32,697,000 -56,238,000 39,333,000 -29,129,000 -27,319,000 -29,721,000 -88,000 -8,779,000 -18,123,000 -23,471,000  -28,729,000 -26,524,000 69,135,000  -17,754,000 -11,060,000 -10,572,000 
      cash flow from investing activities
    		                                       
      purchases of property and equipment
    		-433,000 0 -114,000 -540,000 -2,921,000 -3,494,000 -1,871,000 -1,307,000 -239,000 -1,333,000 -1,840,000 -624,000 -614,000 -632,000 -2,248,000 -2,845,000 -2,344,000 -2,704,000 -84,000 -1,376,000 -1,793,000 -1,841,000 -2,152,000 -1,691,000 -2,245,000 -1,513,000 -718,000 -1,415,000 -938,000 -1,390,000 -1,011,000  -752,000 -362,000 -656,000  -713,000 -1,161,000 -943,000 
      proceeds from the sale of equipment
    		0           0 0       -9,000 7,000   66,000 0 0 36,000 19,000 13,000 0 5,000         
      purchases of marketable securities
    		   4,000 0 3,000 -86,224,000 -38,753,000 -151,581,000 -27,385,000 -40,798,000 -105,404,000 -26,263,000 -123,138,000 -60,381,000 -104,321,000 -110,443,000 -66,705,000 -127,422,000 -158,041,000 -233,979,000 0 -66,384,000 -37,057,000 -198,557,000 -31,877,000 -74,692,000 -108,208,000 -126,697,000 -171,791,000 -52,674,000  -117,610,000       
      proceeds from maturities of marketable securities
    		40,006,000 42,499,000 56,501,000 31,494,000 86,900,000 55,445,000 83,350,000 102,900,000 49,000,000 41,700,000 65,905,000 78,500,000 116,104,000 119,750,000 119,000,000 84,326,000 73,126,000 74,200,000 130,750,000 30,500,000 83,500,000 76,000,000 115,000,000 46,500,000 78,500,000 109,500,000 126,000,000 101,000,000 114,000,000 101,500,000 94,500,000         
      net cash from investing activities
    		39,573,000 42,650,000 56,387,000 30,958,000 83,979,000 51,954,000 -4,745,000 62,840,000 -102,820,000 12,982,000 23,267,000 -27,528,000 89,227,000 -4,002,000 56,371,000 -22,840,000 -39,661,000 4,791,000 3,244,000 -108,894,000 -152,265,000 74,173,000 46,464,000 7,818,000 -122,302,000 76,110,000 50,626,000 -8,604,000 -13,622,000 -71,681,000 40,820,000  -28,847,000 -180,985,000 -656,000  -713,000 -1,161,000 -2,562,000 
      cash flow from financing activities
    		                                       
      repayment on sale of future revenues
    		0 0 -2,872,000                                     
      proceeds from issuance of common stock from at-the-market equity offering
    		                                       
      proceeds from exercise of stock options
    		   1,000 0 0 192,000 30,000 0   7,000 80,000 0 218,000 430,000 2,496,000 16,567,000 12,002,000 8,668,000 947,000 6,839,000 3,047,000 9,107,000 2,137,000 2,086,000 1,533,000 1,952,000 1,451,000 2,515,000 4,410,000  45,000 55,000 435,000     
      proceeds from issuance of common stock under employee stock purchase plan
    		0    0    0                               
      net cash from financing activities
    		17,169,000 7,412,000 -1,437,000 55,513,000 0 322,000 192,000 514,000 0   619,000 80,000 367,000 218,000 1,057,000 2,496,000 17,082,000 261,471,000 9,100,000 822,000 211,153,000 3,047,000 84,569,000 43,353,000 2,369,000 1,533,000 30,352,000 1,240,000 2,667,000 52,681,000  -730,000 -309,000 97,094,000  -22,000 -494,000 98,215,000 
      net increase in cash, cash equivalents, and restricted cash
    		25,899,000 -150,000 7,151,000     41,114,000 -138,279,000 91,796,000 -12,501,000 -69,182,000 41,303,000 -41,480,000 7,362,000 -56,365,000 -77,950,000 -17,084,000 215,236,000 -139,894,000 -206,244,000 254,470,000 -4,575,000                 
      cash, cash equivalents, and restricted cash, beginning of period
    		0 0 135,418,000 0 0 0 127,529,000 0 0 0 145,399,000 0 0 0 207,396,000 0 0 0 143,559,000 0 0 0 239,802,000                 
      cash, cash equivalents, and restricted cash, end of period
    		25,899,000 -150,000 142,569,000 35,709,000 31,391,000 -4,786,000 73,104,000 41,114,000 -138,279,000 91,796,000 132,898,000 -69,182,000 41,303,000 -41,480,000 214,758,000 -56,365,000 -77,950,000 -17,084,000 358,795,000 -139,894,000 -206,244,000 254,470,000 235,227,000                 
      cash and cash equivalents, end of period
    		27,106,000 -150,000 138,692,000 35,709,000 31,391,000 -4,786,000 69,227,000                          -57,554,000 -207,456,000 351,552,000  -17,776,000 -11,554,000 229,204,000 
      restricted cash1
    		-1,207,000 0 3,877,000 0 0 0 3,877,000                                 
      net amortization of premiums and discounts on marketable securities
    		 -257,000 -583,000 -869,000 -1,326,000 -1,880,000 -1,716,000 -2,103,000                                
      proceeds from issuance of common stock from at the market equity offering
    		 7,184,000 1,435,000                                     
      1 as of march 31, 2025 and march 31, 2024, restricted cash of 3,877 and 3,877 was included in restricted cash and other non-current assets on the consolidated balance sheet, respectively.
    		                                       
      non-cash interest expense on liability for sale of future revenues
    		                                       
      other current and non-current liabilities
    		      1,673,000             -3,136,000 -891,000 511,000 833,000 1,124,000 525,000 -878,000 881,000             
      proceeds from offering of common stock, net of issuance costs
    		       0 0       1,000 0 -11,000 249,469,000 -113,000 -125,000   75,125,000    28,318,000 0 -3,000 48,474,000         
      proceeds from sale of future revenues
    		                                       
      issuance of common stock under benefit plans
    		           612,000 0   626,000 0   545,000 0                   
      1as of december 31, 2024, december 31, 2023, and december 31, 2022 restricted cash of 3,877, 3,877, and 3,877, respectively, was included in restricted cash and other non-current assets on the consolidated balance sheet
    		                                       
      net decrease in cash, cash equivalents, and restricted cash
    		      -54,425,000                                 
      1 as of september 30, 2024, restricted cash of 3,877 was included in restricted cash and other non-current assets on the consolidated balance sheet
    		                                       
      1 as of september 30, 2023, restricted cash of 3,878 was included in restricted cash and other non-current assets on the consolidated balance sheet
    		                                       
      supplemental disclosure of cash and non-cash activities:
    		                                       
      1 as of june 30, 2024, restricted cash of 3,877 was included in restricted cash and other non-current assets on the consolidated balance sheet
    		                                       
      1 as of june 30, 2023, restricted cash of 3,877 was included in restricted cash and other non-current assets on the consolidated balance sheet
    		                                       
      1 first quarter 2024 restricted cash of 3,877 was included in restricted cash and other non-current assets on the consolidated balance sheet
    		                                       
      1 first quarter of 2023 restricted cash of 3,877 was included in restricted cash and other non-current assets on the consolidated balance sheet
    		                                       
      fixed asset additions included in accounts payable and accrued expenses
    		      1,644,000 646,000 -13,000 -158,000 370,000 1,027,000 286,000 -72,000 199,000 152,000 -482,000 612,000 467,000 -254,000 481,000 -276,000 705,000 -44,000 676,000 -260,000 356,000 -17,000 305,000 242,000 129,000  143,000 84,000 7,000  -20,000 -262,000 526,000 
      cash paid in connection with operating lease liabilities
    		       3,325,000 3,365,000 1,841,000 3,897,000 2,957,000 4,805,000 3,343,000 3,746,000 4,176,000 2,187,000 2,483,000 4,248,000 2,003,000 2,632,000 2,587,000 2,538,000 1,366,000 1,515,000 1,365,000 1,724,000             
      right-of-use assets obtained in exchange of operating lease obligations
    		       1,683,000 0   25,153,000    983,000 0       0 0 0 19,461,000             
      offering expenses included in accounts payable and accrued expenses
    		                                       
      remeasurement of operating lease liabilities and right-of-use assets due to lease modification
    		          -3,781,000                             
      realized gain on corporate equity securities
    		                                       
      non-cash research and development expenses
    		                                 0 5,000,000     
      proceeds from sale of corporate equity securities
    		                                       
      issuance of common stock for settlement of success payments
    		                  27,500,000          0 0 9,530,000         
      offering costs included in accounts payable and accrued expenses
    		                  10,000  -124,000        0 3,000 19,000         
      unrealized gain on corporate equity securities
    		                    1,416,000 -7,192,000 -7,333,000                 
      non-cash investment in equity securities
    		                           0 0           
      payments on construction financing lease obligation
    		                           -236,000 -211,000 -207,000 -203,000  -175,000 53,000 -443,000     
      reclassification of liability for common stock subject to repurchase
    		                           0 0 1,000 3,000  3,000 3,000 3,000  2,000 3,000 3,000 
      issuance of common stock for repayment of notes payable
    		                                       
      issuance of common stock for asset acquisition
    		                           0 0           
      receivable of proceeds from offering of common stock
    		                                       
      issuances of common stock under benefit plans
    		                       337,000 0   318,000 0           
      payments of notes payable
    		                                       
      non-cash research and development expense
    		                            0 12,500,000 1,942,000         
      right-of-use asset
    		                        -204,000 1,003,000 981,000             
      operating lease liability
    		                        218,000 -946,000 -1,379,000             
      net decrease in cash and cash equivalents
    		                            -20,223,000           
      cash, cash equivalents and restricted cash, beginning of period
    		                        0 0 136,395,000  0 0 148,249,000         
      cash, cash equivalents and restricted cash, end of period
    		                        -105,833,000 52,673,000 159,551,000  -20,223,000 -85,747,000 219,290,000         
      issuance of common stock for settlement of notes payable
    		                            0           
      adjustment to deferred revenue for revenue adoption
    		                              474,000         
      net increase in cash and cash equivalents
    		                         52,673,000 23,156,000    71,041,000 60,088,000 -57,554,000 -207,456,000 166,229,000 -14,551,000 -17,776,000 -11,554,000 86,024,000 
      receivable of proceeds from exercise of stock options
    		                                       
      issuance of common stock for settlement of liabilities
    		                                       
      re-measurement of warrant to purchase redeemable securities
    		                                     0 87,000 
      accretion of redeemable convertible preferred stock to redemption value
    		                                    0 0 47,000 
      reclassification of warrants to additional paid in capital
    		                                       
      conversion of preferred stock to common stock upon closing of the initial public offering
    		                                    0 0 199,915,000 
      payments of notes payables
    		                                       
      net cash provided by:
    		                                       
      operating activities
    		                                       
      investing activities
    		                                       
      financing activities
    		                                       
      changes in restricted cash
    		                                    0 0 -1,619,000 
      proceeds from public offering of common stock, net of issuance costs
    		                                0 -417,000 97,102,000     
      cash and cash equivalents, beginning of period
    		                                0 0 185,323,000  0 0 143,180,000 
      offering costs incurred but unpaid at period end
    		                                  397,000     
      non-cash interest expense
    		                                       
      changes in fair value of warrant liability
    		                                       
      change in fair value of preferred stock tranche asset or liability
    		                                       
      changes in fair value of anti-dilutive protection liability
    		                                       
      changes in deferred rent
    		                                    110,000 110,000 45,000 
      proceeds from equipment loan, net of issuance costs
    		                                       
      proceeds from the issuance of redeemable convertible preferred stock and tranche rights, net of issuance costs
    		                                       
      payments of equipment loan principal
    		                                       
      proceeds from the issuance of common stock and restricted stock
    		                                       
      proceeds from initial public offering of common stock, net of issuance costs
    		                                    -196,000 -498,000 98,182,000 
      proceeds from stock option exercises
    		                                    174,000 4,000 33,000 
      capitalization of construction-in-progress related to facility lease obligation
    		                                    9,919,000 11,027,000 11,649,000 
      initial public offering costs incurred but unpaid at period end
    		                                     -301,000 497,000 
      reclassification of warrants to additional paid-in capital
    		                                    0 0 376,000 
      conversion of anti-dilutive protection liability to common stock
    		                                       
      reclassification of preferred stock tranche liability upon settlement
    		                                       
      accrual of final payment fee on equipment loan and debt discount
    		                                       
      non-cash loss on debt extinguishment
    		                                       
      payments of final fee for loan payoff
    		                                       
      payments of initial public offering costs
    		                                       
      cash paid for interest
    		                                       
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.